Literature DB >> 11524466

Bilateral hippocampal atrophy: consequences to verbal memory following temporal lobectomy.

R C Martin1, S M Sawrie, R C Knowlton, E Bilir, F G Gilliam, E Faught, R B Morawetz, R Kuzniecky.   

Abstract

BACKGROUND: Bilateral hippocampal damage is a risk factor for memory decline after anterior temporal lobectomy (ATL).
OBJECTIVE: To investigate verbal memory outcome in patients with temporal lobe epilepsy (TLE) with either unilateral or bilateral hippocampal atrophy as measured by MRI.
METHODS: The authors selected 60 patients with TLE who had undergone ATL (left = 31, right = 29). They determined normalized MRI hippocampal volumes by cursor tracing 1.5-mm slices from three-dimensional MRI acquisition. Hippocampal volumes were defined as atrophic if the volumes were below 2 SD for control subjects. Bilateral hippocampal atrophy was present in 10 patients with left TLE and 11 patients with right TLE. The authors assessed acquisition, retrieval, and recognition components of verbal memory both before and after ATL.
RESULTS: Groups did not differ across age, education, intelligence, age at seizure onset, or seizure duration. Seizure-free rates after ATL were 70% or higher for all groups. Before surgery, patients with left TLE displayed worse verbal acquisition performance compared with patients with right TLE. Patients with left TLE with bilateral hippocampal volume loss displayed the lowest performance across all three memory components. After surgery, both groups of patients with left TLE exhibited worse verbal memory outcome compared with patients with right TLE. Bilateral hippocampal atrophy did not worsen outcome in the patients with right TLE. A higher proportion of patients with left TLE with bilateral hippocampal atrophy experienced memory decline compared with the other TLE groups.
CONCLUSION: Bilateral hippocampal atrophy in the presence of left TLE is associated with worse verbal memory before and after ATL compared with patients with unilateral hippocampal volume loss or right TLE with bilateral hippocampal volume loss.

Entities:  

Mesh:

Year:  2001        PMID: 11524466     DOI: 10.1212/wnl.57.4.597

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  The Risk-Benefit Ratio for Temporal Lobe Resection in Patients with Bilateral Mesial Temporal Lobe Epilepsy.

Authors:  Lara E Jehi
Journal:  Epilepsy Curr       Date:  2015 Mar-Apr       Impact factor: 7.500

2.  Predicting memory performance in normal ageing using different measures of hippocampal size.

Authors:  T C Lye; D A Grayson; H Creasey; O Piguet; H P Bennett; L J Ridley; J J Kril; G A Broe
Journal:  Neuroradiology       Date:  2005-12-20       Impact factor: 2.804

3.  New evidence supports cognitive decline in temporal lobe epilepsy.

Authors:  Cynthia L Harden
Journal:  Epilepsy Curr       Date:  2007 Jan-Feb       Impact factor: 7.500

Review 4.  Advances in neuroimaging: management of partial epileptic syndromes.

Authors:  Barbara Schäuble; Gregory D Cascino
Journal:  Neurosurg Rev       Date:  2003-08-22       Impact factor: 3.042

5.  Hippocampal volumetry and functional MRI of memory in temporal lobe epilepsy.

Authors:  Dawn Mechanic-Hamilton; Marc Korczykowski; Paul A Yushkevich; Kathy Lawler; John Pluta; Simon Glynn; Joseph I Tracy; Ronald L Wolf; Michael R Sperling; Jacqueline A French; John A Detre
Journal:  Epilepsy Behav       Date:  2009-08-11       Impact factor: 2.937

6.  Inferring Function from Structure: Relationship of Magnetic Resonance Imaging-Detected Hippocampal Abnormality and Memory Function in Epilepsy.

Authors:  Michael Westerveld
Journal:  Epilepsy Curr       Date:  2002-01       Impact factor: 7.872

7.  Hippocampus and Insula Are Targets in Epileptic Patients With Glutamic Acid Decarboxylase Antibodies.

Authors:  Mercè Falip; Laura Rodriguez-Bel; Sara Castañer; Jacint Sala-Padró; Júlia Miro; Sónia Jaraba; Carlos Casasnovas; Francisco Morandeira; Javier Berdejo; Mar Carreño
Journal:  Front Neurol       Date:  2019-01-09       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.